Chardan Capital Cuts Tenaya Therapeutics (NASDAQ:TNYA) Price Target to $9.00
Tenaya Therapeutics (NASDAQ:TNYA – Free Report) had its price target trimmed by Chardan Capital from $18.00 to $9.00 in a ...
Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of Verrica Pharmaceuticals (NASDAQ:VRCA – Free Report) in a research report released on Wednesday,Benzinga reports. Verrica Pharmaceuticals ...